专利检索 ap:("CADILA HEALTHCARE LIMITED") AND inv:"Mukul Hariprasad SHARMA" 第 1 页

1.

发明申请
POLYMORPHIC FORMS OF IVABRADINE HYDROCHLORIDE 有权
标题翻译：戊巴比妥氯化物的多晶型

公开(公告)号：US20160318873A1

公开(公告)日：2016-11-03

申请号：US15168880

申请日：2016-05-31

申请人： CADILA HEALTHCARE LIMITED

发明人： Shriprakash Dhar DWIVEDI , Ashok PRASAD , Mukul Hariprasad SHARMA , Piyush Rajendra SHARMA , Jayprakash Ajitsingh PARIHAR

IPC分类号： C07D223/16

CPC分类号： C07D223/16 , B65B7/02 , B65B31/00 , B65B61/20 , B65D31/02 , B65D31/04 , B65D81/266 , C07B2200/13 , C30B7/02 , C30B29/54 , Y10T428/2982

摘要： Stable crystalline Form II and stable crystalline Form III of ivabradine hydrochloride and processes for their preparation are disclosed.

摘要翻译： 公开了稳定的晶型II和盐酸伊伐布雷定的稳定晶型III及其制备方法。

2.

发明申请
POLYMORPHIC FORMS OF IVABRADINE HYDROCHLORIDE 审中-公开

公开(公告)号：US20170217898A1

公开(公告)日：2017-08-03

申请号：US15485409

申请日：2017-04-12

申请人： CADILA HEALTHCARE LIMITED

发明人： Shriprakash Dhar DWIVEDI , Ashok PRASAD , Mukul Hariprasad SHARMA , Piyush Rajendra SHARMA , Jayprakash Ajitsingh PARIHAR

IPC分类号： C07D223/16 , C30B29/54 , B65B61/20 , B65D81/26 , B65B31/00 , B65B7/02 , C30B7/02 , B65D30/08

CPC分类号： C07D223/16 , B65B7/02 , B65B31/00 , B65B61/20 , B65D31/02 , B65D31/04 , B65D81/266 , C07B2200/13 , C30B7/02 , C30B29/54 , Y10T428/2982

摘要： Stable crystalline Form II and stable crystalline Form III of ivabradine hydrochloride and processes for their preparation are disclosed.

3.

发明申请
A PROCESS FOR PREPARATION OF PYRROLES HAVING HYPOLIPIDEMIC HYPOCHOLESTEREMIC ACTIVITIES 审中-公开
标题翻译：一种制备具有高血压高血压活性的吡咯的方法

公开(公告)号：US20160107989A1

公开(公告)日：2016-04-21

申请号：US14894744

申请日：2014-05-30

申请人： CADILA HEALTHCARE LIMITED

发明人： Shriprakash Dhar DWIVEDI , Ramesh Chandra SINGH , Rajendra Gokalbhai CHAVDA , Jagdish Maganlal PATEL , Daya Ram PAL , Jigar Mukundhai RAVAL , Mukul Hariprasad SHARMA , Pranav Jitendra GANGWAR , Sachin Ashokrao PATIL , Vikas PATEL , Vishwadeepak Rama Patil TRIPATHI

IPC分类号： C07D207/32

CPC分类号： C07D207/333 , A61K31/402 , C07D207/32 , C07D207/325

摘要： The present invention provides pyrroles having hypolipidemic hypocholesteremic activities. The invention provides saroglitazar and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs or intermediates thereof. The invention also provides a process for the preparation of saroglitazar. The invention further provides intermediates as well process for preparation thereof.

摘要翻译： 本发明提供了具有降血脂低胆固醇活性的吡咯。本发明提供了saroglitazar及其药学上可接受的盐，水合物，溶剂合物，多晶型物或其中间体。本发明还提供了一种制备赛格列唑的方法。本发明还提供中间体以及其制备方法。